INTELLECTUAL PROPERTY AND PATENTS. 27.1 Intellectual property consists of inventions, publications, computer software, courseware, works of art and music, data bases, lecture notes, laboratory manuals, articles, books, as well as all other creations that can be protected under patent, copyright, trademark or similar laws.
27.2 Copyright is owned by the members who create intellectual property, except in either of the following cases:
27.2.1 where there is a written contract to the contrary between the member, the Employer, and/or a third party which assigns some or all ownership rights of the intellectual property to the Employer or the third party. The member shall negotiate such an agreement with the assistance of a representative of the Faculty Association;
27.2.2 where the Employer provides funds, resources, and facilities to the member beyond those required for the payment of the member’s salary and benefits or for the provision of a normal academic environment in which to work, in which case the member shall, with the assistance of a representative of the Faculty Association, come to agreement with the Vice-President (Academic) on sharing ownership rights to the intellectual property with the Employer.
27.3 The Employer has a non-exclusive, royalty-free, irrevocable, indivisible, and non- transferable right to retain for archival purposes and to use for internal educational and research purposes only any intellectual property developed by members with the use of the Employer’s time, facilities, and resources. Such right shall not include the right to transfer, license, exploit or use the intellectual property for distance education or for any purpose other than the internal use of the University.
27.4 Members have intellectual and artistic freedom in the creation of intellectual property and the right to disseminate the intellectual property which they own. Such right shall not include the right to transfer, licence, exploit, or use intellectual property developed and/or delivered through the Department of Distance Learning and Continuing Education under the terms of Article 25 without the agreement of the Employer.
INTELLECTUAL PROPERTY AND PATENTS. 2.5.1 Both the supervisor and student are aware that intellectual property, including data generated during postgraduate research and study, belongs to Stellenbosch University, according to the SU IP policy. Copies of all data (raw and analysed) must be submitted to the supervisor on completion of the study (General Policies and Rules: Calendar Part 1) (In case of any IP related queries please contact Innovus).
INTELLECTUAL PROPERTY AND PATENTS. (a) Xxxxxx will retain and own all right, title and interest in and to any intellectual property (x) that Xxxxxx owned or had rights to before the date of the order subject to these General Terms and/or (y) on Goods that result from use of Buyer’s designs, specifications or instructions. Consequently, by submitting designs, specifications or instructions to Xxxxxx, Buyer irrevocably agrees that Xxxxxx shall be free to use the same, free of charge, and in the broadest possible manner (and not only to manufacture Goods for Buyer), for the entire period of protection afforded to intellectual property rights (including any extension thereof) which could cover Buyer’s designs, specifications or instructions. To the extent any aspects of any Goods resulting from the use of Buyer’s designs, specifications or instructions is not automatically the exclusive property of Safran, Buyer hereby irrevocably assigns to Safran, on an exclusive basis, free of charge, all right, title and interest in and to any intellectual property on any such Goods, allowing Xxxxxx to use and exploit the same in any part of the world and for the entire duration of protection of said intellectual property rights, including in particular the exclusive right to exploit, reproduce, present, adapt, modify, translate, distribute, license, sell, market and use the same, in the broadest possible manner, for the entire period of protection afforded to intellectual property rights (including any extension thereof). Such assignment is made without limitation as to the number of reproductions or presentations that may be made, in all countries and in all languages, by all means of exploitation and on all current or future types of media, including computer media, multimedia, networks, including the internet, and by direct or satellite broadcasting. The sale of Goods (including if manufactured according to Buyer’s designs, specifications or instructions) or any parts thereof hereunder confers on Buyer no license under any patent or other intellectual property rights of Safran covering or relating inter alia to (i) the structure of any devices to which the Goods or parts may be applied or (ii) a process or machine in connection with which they may be used, and does not allow Buyer to create or develop derivatives works or products from the Goods thereafter.
(b) Buyer will indemnify, defend and hold Safran harmless against any losses, liabilities, damages, costs or expenses, including, without limitation...
INTELLECTUAL PROPERTY AND PATENTS. (a) Intellectual Property (“IP”) means all copyright and all rights in relation to inventions (including patent rights), registered and unregistered trademarks (including service marks), registered and unregistered designs, circuit layouts, and any other rights resulting from intellectual activity in the industrial, scientific, literary and artistic fields recognised in domestic law anywhere in the world.
(b) Where IP is owned and supplied by a party (whether separately or as part of the Goods), that party shall retain ownership of all such IP. The other party undertakes not to disclose any information related to such IP to any third parties without the prior written consent of the first party, except where it is necessary for the usual or intended use of the Goods.
(c) The ownership in IP which is created under or otherwise in connection with the PO, shall vest in the party which created such IP. In case that the Purchaser is not be the owner of such IP, then the Purchaser shall be granted by the owner of such IP, a royalty-free, irrevocable, world-wide, perpetual, non-exclusive, unrestricted license regarding such IP. Said licence shall not be limited to a particular project or purpose, shall include the right to sub-license and all documentation, data, samples or any other materials developed or created in connection with such IP.
(d) Supplier warrants that Goods supplied – other than Goods supplied in accordance with technical plans or drawings provided to Supplier by Purchaser – do not infringe any IP, and shall hold harmless and indemnify Purchaser from and against all claims and proceedings for or on account of such infringements in respect of Goods supplied by Supplier and from and against all related claims, demands, proceedings, damages, costs, charges and expenses.
INTELLECTUAL PROPERTY AND PATENTS. 2.1. The Employee undertakes to immediately bring to Teva’s attention or the attention of whoever is designated by Teva, all Confidential Information or other information, created, developed or which came to Employee’s attention and which relates to Teva’s field of operations, including any improvement, invention, innovation, process, creation, discovery, formula, technique, conclusions, knowledge, findings, research results, examination or experiment, developments, designs, ideas, etc., whether or not patentable or eligible to be protected as another proprietary right, whether or not forming the subject-matter of an application for registration of the right, whether or not it constitutes a service invention in accordance with the law, which were made, conceived, produced or implemented, developed or formed, in whole or in part, by the Employee alone or jointly with others, in Israel or abroad, during the Term of Employment at Teva or in connection with the Employee’s work at Teva (hereinafter, jointly and severally: “Information Created by the Employee”). For the avoidance of any doubt, it is hereby clarified that Information Created by the Employee will include, inter alia, information created, formed or developed after the commencement of the Term of Employment (even if conceived or developed prior to the execution of this Letter of Undertaking) and/or after termination thereof, provided that the information relates, directly or indirectly, to the Employee’s work and/or employment with Teva
2.2. The Employee hereby represents and confirms that all the rights in and to the Information Created by the Employee, including, without derogating from the generality of the foregoing, in service inventions, as such term is defined in the Patents Law, 5727-1967 (the “Patents Law”), as may be amended from time to time, and in anything relating thereto, are, as of the time of their creation, the sole property of Teva, and that the Employee does not and will not have any rights, demands, or claims in connection with the proprietary rights and/or other rights of any kind whatsoever, including any monetary demand, other than the salary payable to the Employee by Teva and other benefits to which Employee is entitled, and the Employee will not be entitled to any moral rights (if any), royalties and/or any payment whatsoever, in consideration for and/or in connection with the Information Created by the Employee and/or its commercial use and/or other use or its transfer an...
INTELLECTUAL PROPERTY AND PATENTS. 9.1 Inventorship shall be determined according to United States Patent law.
9.2 All right and title to EMORY Intellectual Property shall belong to EMORY and shall not be subject to the terms and conditions of this Agreement. No rights in EMORY Intellectual Property are provided to CBT under any patents, patent applications, trade secrets or other proprietary rights of EMORY.
9.3 All right and title to CBT Intellectual Property shall belong to CBT and shall not be subject to the terms and conditions of this Agreement. No rights in CBT Intellectual Property are provided to EMORY under any patents, patent applications, trade secrets or other proprietary rights of CBT.
9.4 All right and title to EMORY Project Intellectual Property shall belong to EMORY and shall be Licensed Patents or Licensed Technology, and shall be subject to the rights and obligations and terms and conditions of the License Agreement.
9.5 All right and title to Joint Project Intellectual Property shall belong jointly to EMORY and to CBT and shall be Licensed Patents or Licensed Technology, and shall be subject to the terms and conditions of the License Agreement.
9.6 All right and title to Other EMORY Project Intellectual Property shall belong to EMORY and shall be subject to the terms and conditions of this Agreement.
9.7 All right and title to Other Joint Project Intellectual Property shall belong jointly to EMORY and to CBT and shall be subject to the rights and obligations and terms and conditions of this Agreement.
9.8 Within sixty (60) days of receiving a disclosure of EMORY Project Intellectual Property from the Principal Investigator and/or Investigators, EMORY shall fully disclose such EMORY Project Intellectual Property to CBT. CBT agrees to hold all such EMORY disclosures in confidence until a patent application(s) is filed to protect any invention(s) encompassed within the EMORY Project Intellectual Property, as provided for herein. Within sixty (60) days of receiving such disclosure from EMORY, CBT shall notify EMORY in writing if it wants EMORY to pursue patent protection for the EMORY Project Intellectual Property. Pursuant to Paragraph 7.1.1 of the License Agreement. EMORY shall be primarily responsible for all patent prosecution activities pertaining to the EMORY Project Intellectual Property. Pursuant to Paragraph 7.1.2 of the License Agreement, CBT shall bear all out-of-pocket costs in connection with such preparation, filing, prosecution, and maintenance of U.S. and for...
INTELLECTUAL PROPERTY AND PATENTS. The Buyer shall hold REFRACTRON harmless against any expenses, damages, costs, or losses resulting from any suit or proceeding brought for infringement of patents, copyrights, trademarks or trade secrets or for unfair competition arising from compliance with Buyer’s designs or specifications or instructions.
INTELLECTUAL PROPERTY AND PATENTS. ImmunoClin, Ltd’s intellectual property and patents are including, but are not limited to, the following: All intellectual property created by ImmunoClin, Ltd and All patents filed, in-process, or contemplated by ImmunoClin, Ltd. MARKER GENE IMMUNOCLIN, LTD. (United Kingdom) OSAKA INDUSTRIAL PROMOTION ORGANISATION (JAPAN) 16.10.2002 BIOMARKERS OF RESISTANCE TO INFECTIONS IN HUMANS AND BIOLOGICAL APPLICATION THEREOF (IL-22) INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (IRD) (France) IMMUNOCLIN, LTD. (United Kingdom) 5.11.2003
INTELLECTUAL PROPERTY AND PATENTS. (a) Safran will retain and own all right, title and interest in and to any intellectual property (x) that Safran owned or had rights to before the date of the order subject to these General Terms and/or (y) on Goods that result from use of Buyer’s designs, specifications or instructions. Consequently, by submitting designs, specifications or instructions to Safran, Buyer irrevocably agrees that Safran shall be free to use the same, free of charge, and in the broadest possible manner (and not only to manufacture Goods for Buyer), for the entire period of protection afforded to intellectual property rights (including any extension thereof) which could cover Buyer’s procesadores) sin la autorización previa y expresa por escrito de la otra parte. Ninguna de las partes copiará, almacenará o transferirá a otros países los Datos Personales sin la autorización previa y expresa por escrito de la otra parte.
INTELLECTUAL PROPERTY AND PATENTS. The Ekosolve process has a number of inventions and techniques to achieve the extremely high recovery of lithium from saltwater brines. The Board has decided at this stage to keep the intellectual property a trade secret between the inventors and the University. While some of the components are readily available, it took more than five years research and collaboration to refine the final Ekosolve™ process. There are many trade secret chemical processes that have been able to protect their processes, the most famous being Coca-Cola™ and Kentucky Fried Chicken™. The Board is leaving open the possibility of patenting in USA, Australia and Europe any developments of “Prior Art” Inventions that may result from the development of the Ekosolve™ Process over time. However, as at the date of this Information Memorandum, the Company has no patents, patent applications or other formal means of intellectual property protection.
